Skip to main content
Clinical Trials/NCT01469117
NCT01469117
Completed
N/A

Enteral Formula Tolerance In Pediatric Patients With Developmental Disabilities

Société des Produits Nestlé (SPN)1 site in 1 country16 target enrollmentNovember 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Developmental Disabilities
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
16
Locations
1
Primary Endpoint
Time to feeding goal achievement
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This is a single center, prospective, non-randomized, uncontrolled, observational study of the use of an enteral nutrition product in pediatric patients with developmental disabilities.

Detailed Description

This prospective observational study seeks to assess ability to achieve enteral feeding goals with a new tube feeding product in pediatric patients with developmental disabilities.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
January 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Child aged 1-13 years old with development disabilities
  • Currently tolerating enteral feeding
  • Requiring nutritional management to meet 50-90th% weight for age on the Kennedy Kreiger Growth Charts
  • Requires enteral tube feeding for at least 14 days.

Exclusion Criteria

  • Unable to access gastrointestinal tract for feeding via tube
  • Other condition which contraindicates tube feeding

Outcomes

Primary Outcomes

Time to feeding goal achievement

Time Frame: up to 14 days

Secondary Outcomes

  • Percentage of nutrition goal met(daily up to 21 days)
  • Gastrointestinal measures assessment(up to 21 days)
  • Serum biochemical markers assessment(baseline and completion of study)
  • Assessment of frequency and nature of adverse events(daily up to 21 days)

Study Sites (1)

Loading locations...

Similar Trials